drug patentとは 意味・読み方・使い方

Article 50 For the benefit of public health, the patent administration department under the State Council may grant a compulsory license for manufacture of the drug, for which a patent right has been obtained, and for its export to the countries or regions that conform to the provisions of the relevant international treaties to which the People's Republic of China has acceded.発音を聞く 例文帳に追加

第五十条 公共の健康を目的として特許権を取得した薬品について、国務院専利行政部門はこれを製造し、中華人民共和国が締結した関連の国際条約の規定に合致する国または地域に輸出することを強制許諾することができる。 - 特許庁

The following dispositions are designated by the Cabinet Order: the registration of agricultural chemicals under the Agricultural Chemicals Regulation Law and the approval and certification of drug products under the Pharmaceutical Affairs Law (Article 3 of the Order for Enforcement of the Patent Act).発音を聞く 例文帳に追加

政令で定める処分としては、農薬取締法の規定に基づく農薬に係る登録、薬事法の規定に基づく医薬品に係る承認・認証が、規定されている(特許法施行令第3条)。 - 特許庁

When the act of manufacturing and marketing the drug product or the act of manufacturing or importing the agricultural chemical that was the subject of the present disposition does not constitute an act of working the patented invention to which the application to register a patent term extension pertains発音を聞く 例文帳に追加

本件処分の対象となった医薬品の製造販売の行為又は農薬の製造・輸入の行為が、延長登録の出願に係る特許発明の実施行為に該当しない場合 - 特許庁

From this perspective, given the situation under the present drug pricing system where, even during the patent life, drug prices are structured to fall continuously and moreover are used for comparison in the calculation of drug prices, even the corrected prices of new drugs are likely to fall below the level in the major European countries and the US, leading to more increases rather than reductions on the application of the foreign price adjustment. In respect of drugs which thus are expected to be more highly priced abroad than in Japan, it has been pointed out that launch overseas gives more favorable drug pricing and that the pricing system has become unfavorable to domestic lead-off development.例文帳に追加

この観点からみると、現在の薬価制度の下では、特許期間中でも薬価が継続的に下落し得る構造になっており、また、そのような価格を比較対照として薬価を算定した場合、加算後の薬価であっても欧米主要国の新薬の薬価水準よりも低い傾向があり、外国平均格調整で引下げとなる場合よりも引上げとなる場合が多くなる傾向がある。このように、海外で我が国よりも高い薬価が期待できる医薬品については、海外で先に上市した方が薬価算定に有利であり、国内先行開発に不利な算定方式になっている等の指摘がある。 - 厚生労働省

If the drug product or agricultural chemical that was the subject of the present disposition simultaneously satisfies all of the matters to define patented inventions that are described in multiple claims under the relevant patent right, it means that there are multiple “parts of the patented invention that are defined by the ‘matters falling under the matters to define the invention (and the use)’ of the drug product or agricultural chemical that was the subject of the present disposition.”発音を聞く 例文帳に追加

本件処分の対象となった医薬品又は農薬が本件特許権の複数の請求項に係る特許発明の発明特定事項のすべてを同時に備えている場合には、「特許発明のうち、本件処分の対象となった医薬品又は農薬の『発明特定事項(及び用途)に該当する事項』によって特定される範囲」は、複数存在する。 - 特許庁

(3) In this section: pharmaceutical patent means a patent claiming: (a) a pharmaceutical substance; or (b) a method, use or product relating to a pharmaceutical substance, including any of the following: (i) a method for producing a raw material needed to produce the substance; (ii) a product that is a raw material needed to produce the substance; (iii) a product that is a pro-drug, metabolite or derivative of the substance.発音を聞く 例文帳に追加

(3) 本条において，「医薬特許」とは，(a) 医薬物質，又は (b) 医薬物質に関連する方法，用途又は製品で，次の何れか，すなわち，(i) 当該物質を製造するために必要な原料を製造する方法， (ii) 当該物質を製造するために必要な原料である製品， (iii) 当該物質のプロドラッグ，代謝産物又は派生物である製品，をクレームする特許を意味する。 - 特許庁

Such legal regulations themselves are indispensable due to the importance of their role. However, these regulations have prevented inventors in the particular fields, such as drug products, from enjoying the benefits of their patent rights during the period required for approval.発音を聞く 例文帳に追加

このような法規制そのものは、その趣旨からして必要欠くべからざるものであるが、その結果として医薬品等の分野では、その分野全体として、本来享受できるはずの特許期間がその規制に係る分だけ享受しえないこととなっている。 - 特許庁

When such part of the patented invention to which the application to register a patent term extension pertains that is defined by the “matters falling under the matters to define the invention (and the use)” (see 2.5 (4) and 3.1.1 (1)) of the drug product or agricultural chemical that was the subject of the present disposition has been able to be worked by a prior disposition発音を聞く 例文帳に追加

延長登録の出願に係る特許発明のうち、本件処分の対象となった医薬品又は農薬の「発明特定事項(及び用途)に該当する事項」(2.5(4)、3.1.1(1)参照)によって特定される範囲が、先行処分によって実施できるようになっていた場合 - 特許庁